A. Baranowski

ORCID: 0000-0002-1595-9092 · 10 papers in corpus
review 2022
Myofascial Pelvic Pain: Best Orientation and Clinical Practice. Position of the European Association of Urology Guidelines Panel on Chronic Pelvic Pain
European urology focus ·doi:10.1016/j.euf.2022.07.007

CONTEXT: Despite the high prevalence of a myofascial pain component in chronic pelvic pain (CPP) syndromes, awareness and management of this component are lacking among health care providers. OBJECTIVE: To summarize the current state of th…

review 2021
Management of chronic primary pelvic pain syndromes
BJU international ·doi:10.1111/bju.15609

Management of chronic pelvic pain (CPP) remains a huge challenge for care providers and a major burden for healthcare systems. Treating chronic pain that has no obvious cause warrants an understanding of the difficulties in managing these c…

rct 2020
Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial
Lancet (London, England) ·doi:10.1016/s0140-6736(20)31693-7

BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in w…

2018
GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol
·doi:10.60692/6nvwt-mjd92

Chronic pelvic pain (CPP) affects more than 1 million UK women with associated healthcare costs of £158 million annually. Current evidence supporting interventions when no underlying pathology is identified is very limited and treatment is …

rct 2018
GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol
BMJ open ·doi:10.1136/bmjopen-2016-014924

INTRODUCTION: Chronic pelvic pain (CPP) affects more than 1 million UK women with associated healthcare costs of £158 million annually. Current evidence supporting interventions when no underlying pathology is identified is very limited and…

other 2014
Pelvic pain: a pathway for care developed for both men and women by the British Pain Society
British journal of anaesthesia ·doi:10.1093/bja/aet421

This paper aims to explain the key points and highlight some of the controversies in the development of the British Pain Society's pelvic pain patient pathway map. Many clinicians lack experience and confidence with this group of patients, …

2013
Taxonomy of Pelvic Pain
·doi:10.1007/978-3-642-28753-4_4934
meta-analysis 2013
The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development
European urology ·doi:10.1016/j.eururo.2013.04.035

CONTEXT: Progress in the science of pain has led pain specialists to move away from an organ-centred understanding of pain located in the pelvis to an understanding based on the mechanism of pain and integrating, as far as possible, psychol…

meta-analysis 2009
EAU guidelines on chronic pelvic pain
European urology ·doi:10.1016/j.eururo.2009.08.020

CONTEXT: These guidelines were prepared on behalf of the European Association of Urology (EAU) to help urologists assess the evidence-based management of chronic pelvic pain (CPP) and to incorporate the recommendations into their clinical p…

other 2008
Sex, Gender and Pain
Reviews in pain ·doi:10.1177/204946370800200202

As we come towards the end of IASP's Global Year Against Pain in Women we may wish to take time to think about the differences and similarities between men and women's suffering of pain and to consider the role of sex and gender. Sex is the…